Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features.
To further define the clinical, pathologic, and biochemical features of hemorrhagic shock and encephalopathy syndrome, we studied 25 affected children (aged 3 months to 14 years) admitted to a single center between 1982 and 1985. A prodromal illness comprising vomiting, diarrhea, listlessness, and fever was present in 84% of the cases. Acute onset of shock, convulsions and coma, bleeding (or laboratory evidence of disseminated intravascular coagulation), elevated plasma activity of hepatic enzymes, acidosis, and impaired renal function was present in every case. Twenty patients died, and all the survivors are neurologically damaged. At postmortem examination, intravascular microthrombi coexisting with hemorrhages and petechiae were found in most organs. Centrilobular liver necrosis and cerebral edema were prominent features. No microbiologic cause for the disorder was identified, but decreased plasma levels of the protease inhibitors alpha 1-antitrypsin and alpha 2-macroglobulin, together with increased levels of circulating proteolytic enzymes, were frequently present. An overrepresentation of the uncommon variant phenotypes of alpha 1-antitrypsin was found in first-degree relatives of affected patients (four had the MZ phenotype, and one each the MS or MC phenotype, of 19 relatives studied). Abnormal accumulation of alpha 1-antitrypsin was detected immunohistochemically in the livers of six of the patients. Defective protease inhibitor production or release may be involved in the pathogenesis of the disorder.
Levin
M
M
Infectious Diseases Unit, Hospital for Sick Children, London, United Kingdom.
Pincott
J R
JR
Hjelm
M
M
Taylor
F
F
Kay
J
J
Holzel
H
H
Dinwiddie
R
R
Matthew
D J
DJ
D000293:Adolescent; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D003128:Coma / Q000097:blood / Q000150:complications / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010641:Phenotype; D012771:Shock, Hemorrhagic / Q000097:blood / Q000150:complications / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D013577:Syndrome; D000515:alpha 1-Antitrypsin / Q000032:analysis
D001798:Blood Proteins; D000515:alpha 1-Antitrypsin